Oertel, Wolfgang
Philipps University of Marburg · Helmholtz Munich
14 papers on CoChatORCID 0000-0002-7582-8166
Most cited papers
- Verified
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders
Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders
Cited by 7,653
- Verified
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease
Neuroinflammation and Neurodegeneration MechanismsParkinson's Disease Mechanisms and Treatments
Cited by 1,200
- Verified
The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder
Heintz‐Buschart, A., Pandey, U., Wicke, T., Sixel‐Döring, F., Janzen, A., Sittig‐Wiegand, E., Trenkwalder, C., Oertel, W. H., Mollenhauer, B., & Wilmes, P. (2018) · Movement Disorders
Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health
Cited by 554
- Verified
Validation of the freezing of gait questionnaire in patients with Parkinson’s disease
Giladi, N., Tal, J., Azulay, T., Rascol, O., Brooks, D. J., Melamed, E., Oertel, W., Poewe, W. H., Stocchi, F., & Tolosa, E. (2009) · Movement Disorders
Balance, Gait, and Falls PreventionParkinson's Disease Mechanisms and Treatments
Cited by 431
- Verified
The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease
Höglinger, G. U., Breunig, J. J., Depboylu, C., Rouaux, C., Michel, P. P., Alvarez-Fischer, D., Boutillier, A.-L., DeGregori, J., Oertel, W. H., Rakic, P., et al. (2007) · Proceedings of the National Academy of Sciences
Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling
Cited by 276
- Verified
Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease
Riedel, O., Klotsche, J., Spottke, A., Deuschl, G., Förstl, H., Henn, F., Heuser, I., Oertel, W., Reichmann, H., Riederer, P., et al. (2010) · Journal of Neurology
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 256
- Verified
Cognitive impairment in 873 patients with idiopathic Parkinson's disease: Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD)
Riedel, O., Klotsche, J., Spottke, A., Deuschl, G., Förstl, H., Henn, F., Heuser, I., Oertel, W., Reichmann, H., Riederer, P., et al. (2008) · Journal of Neurology
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 254
- Verified
Men and women are different: Diffusion tensor imaging reveals sexual dimorphism in the microstructure of the thalamus, corpus callosum and cingulum
Menzler, K., Belke, M., Wehrmann, E., Krakow, K., Lengler, U., Jansen, A., Hamer, H. M., Oertel, W. H., Rosenow, F., & Knake, S. (2011) · NeuroImage
Advanced Neuroimaging Techniques and ApplicationsSex and Gender in Healthcare
Cited by 237
- Verified
Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults
Alvarez-Fischer, D., Fuchs, J., Castagner, F., Stettler, O., Massiani-Beaudoin, O., Moya, K. L., Bouillot, C., Oertel, W. H., Lombès, A., Faigle, W., et al. (2011) · Nature Neuroscience
Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling
Cited by 150
- Verified
Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case–control study
Ferini-Strambi, L., Oertel, W., Dauvilliers, Y., Postuma, R. B., Marelli, S., Iranzo, A., Arnulf, I., Birgit, H., Manni, R., Miyamoto, T., et al. (2014) · Journal of Neurology
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 112
- Verified
Postprandial ghrelin response is reduced in patients with Parkinson’s disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson’s disease?
Unger, M. M., Möller, J. C., Mankel, K., Eggert, K. M., Bohne, K., Bodden, M., Stiasny-Kolster, K., Kann, P. H., Mayer, G., Tebbe, J. J., et al. (2011) · Journal of Neurology
Parkinson's Disease Mechanisms and TreatmentsRegulation of Appetite and Obesity
Cited by 97
- Verified
Rational therapeutic approaches to progressive supranuclear palsy
Stamelou, M., de Silva, R., Arias-Carrion, O., Boura, E., Hollerhage, M., Oertel, W. H., Muller, U., & Hoglinger, G. U. (2010) · Brain
Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments
Cited by 91
- Verified
Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy
Winter, Y., Schepelmann, K., Spottke, A. E., Claus, D., Grothe, C., Schröder, R., Heuss, D., Vielhaber, S., Tackenberg, B., Mylius, V., et al. (2010) · Journal of Neurology
Neurogenetic and Muscular Disorders ResearchHealth Systems, Economic Evaluations, Quality of Life
Cited by 86
- Verified
Widespread microglial activation in multiple system atrophy
Kübler, D., Wächter, T., Cabanel, N., Su, Z., Turkheimer, F. E., Dodel, R., Brooks, D. J., Oertel, W. H., & Gerhard, A. (2019) · Movement Disorders
Neuroinflammation and Neurodegeneration MechanismsParkinson's Disease Mechanisms and Treatments
Cited by 61
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free